Biotricity Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Biotricity are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Biotricity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Biotricity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 570.5 K |
Biotricity |
Biotricity Relative Risk vs. Return Landscape
If you would invest (100.00) in Biotricity on December 14, 2024 and sell it today you would earn a total of 100.00 from holding Biotricity or generate -100.0% return on investment over 90 days. Biotricity is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of otc stocks are less volatile than Biotricity, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Biotricity Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Biotricity's investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as Biotricity, and traders can use it to determine the average amount a Biotricity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| BTCY |
Based on monthly moving average Biotricity is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Biotricity by adding Biotricity to a well-diversified portfolio.
Biotricity Fundamentals Growth
Biotricity OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Biotricity, and Biotricity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Biotricity OTC Stock performance.
| Return On Equity | -41.01 | ||||
| Return On Asset | -0.89 | ||||
| Profit Margin | (1.17) % | ||||
| Operating Margin | (0.96) % | ||||
| Current Valuation | 38.87 M | ||||
| Shares Outstanding | 21.48 M | ||||
| Price To Earning | (6.70) X | ||||
| Price To Book | 33.02 X | ||||
| Price To Sales | 0.83 X | ||||
| Revenue | 12.06 M | ||||
| EBITDA | (8.82 M) | ||||
| Cash And Equivalents | 2.89 M | ||||
| Cash Per Share | 0.05 X | ||||
| Total Debt | 23.88 M | ||||
| Debt To Equity | 6.45 % | ||||
| Book Value Per Share | (3.31) X | ||||
| Cash Flow From Operations | (6.69 M) | ||||
| Earnings Per Share | (1.66) X | ||||
| Total Asset | 5.94 M | ||||
| Retained Earnings | (127.5 M) | ||||
| Current Asset | 11 K | ||||
| Current Liabilities | 303 K | ||||
Things to note about Biotricity performance evaluation
Checking the ongoing alerts about Biotricity for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Biotricity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Biotricity is not yet fully synchronised with the market data | |
| Biotricity has some characteristics of a very speculative penny stock | |
| Biotricity has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.06 M. Net Loss for the year was (14.09 M) with profit before overhead, payroll, taxes, and interest of 4.57 M. | |
| Biotricity currently holds about 2.89 M in cash with (6.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05. | |
| Roughly 49.0% of the company shares are held by company insiders |
- Analyzing Biotricity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Biotricity's stock is overvalued or undervalued compared to its peers.
- Examining Biotricity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Biotricity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Biotricity's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of Biotricity's otc stock. These opinions can provide insight into Biotricity's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Note that the Biotricity information on this page should be used as a complementary analysis to other Biotricity's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Consideration for investing in Biotricity OTC Stock
If you are still planning to invest in Biotricity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotricity's history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |